✨ Medicines Consent Notices
2962 NEW ZEALAND GAZETTE No. 117
Product:
Diprivan 1% w/v
Active Ingredient(s):
Propofol 10mg/mL
Dosage Form:
Solution for injection (prefilled syringe)
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer(s):
Zeneca SpA, Caponago, Milan, Italy
Product:
Diprivan 1% w/v
Active Ingredient(s):
Propofol 10mg/mL
Dosage Form:
Emulsion for injection (ampoule)
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer(s):
Pharmacia & Upjohn AB, Uppsala, Sweden
Zeneca SpA, Caponago, Milan, Italy
Product:
Intron-A
Active Ingredient(s):
Interferon alfa-2b 5MIU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Inc, Union, New Jersey, United States of America
Product:
Prograf
Active Ingredient(s):
Tacrolimus 1mg
Dosage Form:
Capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer(s):
Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire
Product:
Prograf
Active Ingredient(s):
Tacrolimus 5mg
Dosage Form:
Capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer(s):
Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire
Product:
Prograf
Active Ingredient(s):
Tacrolimus 5mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer(s):
Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire
Product:
Taxotere
Active Ingredient(s):
Docetaxel (trihydrate) 40mg/mL
Dosage Form:
Solution for concentrate for infusion
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer(s):
Rhone-Poulenc Rorer Limited, Dagenham, Essex, United Kingdom
Rhone-Poulenc Rorer SA, Vitry sur Seine, France
Note: This product has provisional consent.
Dated this 24th day of August 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go645i
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Optilast
Active Ingredient(s):
Azelastine hydrochloride 0.05%w/v
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
3M New Zealand Limited
Manufacturer(s):
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product:
Rebif
Active Ingredient(s):
Interferon beta 1a (recombinant chinese hamster) 22µg equivalent to 6 MIU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer(s):
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 117
Gazette.govt.nz —
NZ Gazette 2000, No 117
✨ LLM interpretation of page content
🏥
Consent to Distribution of Changed Medicines
(continued from previous page)
🏥 Health & Social Welfare24 August 2000
Medicines, Distribution, Diprivan, Propofol, Intron-A, Interferon alfa-2b, Prograf, Tacrolimus, Taxotere, Docetaxel
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines, Distribution, Optilast, Azelastine hydrochloride, Rebif, Interferon beta 1a